Indications
Ipreziv is indicated for the treatment of essential hypertension in adults.
Composition
- Active substance
- azilsartan medoxomil
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ipreziv
- Active substance
- azilsartan medoxomil
- ATC code
- C09CA09
- Therapeutic area
- Hypertension
- Marketing authorisation holder
- Takeda Pharma A/S
- Status
- Withdrawn
- EU authorisation
- 7 Dec 2011
- Withdrawn
- 27 Oct 2014